216 related articles for article (PubMed ID: 12851616)
1. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Melenovsky V; Stulc T; Kozich V; Grauova B; Krijt J; Wichterle D; Haas T; Malik J; Hradec J; Ceska R
Am Heart J; 2003 Jul; 146(1):110. PubMed ID: 12851616
[TBL] [Abstract][Full Text] [Related]
2. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
Dierkes J; Westphal S; Luley C
Expert Opin Drug Saf; 2004 Mar; 3(2):101-11. PubMed ID: 15006716
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
6. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
Moat SJ; Bonham JR; Powers HJ
Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421
[TBL] [Abstract][Full Text] [Related]
7. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
8. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine elevation with fibrates: is it a class effect?
Harats D; Yodfat O; Doolman R; Gavendo S; Marko D; Shaish A; Sela BA
Isr Med Assoc J; 2001 Apr; 3(4):243-6. PubMed ID: 11344833
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
[TBL] [Abstract][Full Text] [Related]
13. Physical training decreases total plasma homocysteine and cysteine in middle-aged subjects.
Gaume V; Mougin F; Figard H; Simon-Rigaud ML; N'Guyen UN; Callier J; Kantelip JP; Berthelot A
Ann Nutr Metab; 2005; 49(2):125-31. PubMed ID: 15860911
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
[TBL] [Abstract][Full Text] [Related]
15. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
16. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
17. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 12-week treatment with fenofibrate 300 mg in Thai dyslipidemic patients.
Koanantakul B; Jeamanukulkit N; Piamsomboon C; Chawantanpipat C; Khanacharoen I
J Med Assoc Thai; 2004 Nov; 87(11):1281-5. PubMed ID: 15825700
[TBL] [Abstract][Full Text] [Related]
19. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
[TBL] [Abstract][Full Text] [Related]
20. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]